Menu
Surgical Intervention
Minor Clinic Intervention
Minor Clinic Intervention Invasive Day Surgery / Outpatient

Non-Tunneled Dialysis Catheter Placement (Quinton)

Protocol / Details

Standard placement of a non-tunneled dialysis catheter via the internal jugular vein using ultrasound guidance. Procedure involves sterile preparation, local anesthesia with 1% lidocaine, venous cannulation via Seldinger technique, guidewire insertion, tract dilation, catheter placement, and securement with sutures and sterile dressing.

Procedure Type
Surgery / Invasive
Estimated Base Cost
Varies by patient
Medical & Surgical Disclaimer The clinical information provided regarding this procedure is for educational purposes only. Only a qualified specialist or surgeon can determine if you are a suitable candidate for this intervention after a thorough examination.

Verify patient identity and consent. Confirm coagulation profile (INR/PTT) and platelet count. Ensure ultrasound availability. Perform a 'timeout' procedure. Position patient in Trendelenburg position. Prepare the neck and upper chest area with chlorhexidine solution.

Immediate post-procedure chest X-ray to confirm catheter tip position and rule out pneumothorax. Monitor vital signs for 30 minutes. Ensure bleeding at the insertion site has stopped. Provide discharge instructions including signs of infection and prohibited physical activities. Patient discharged on the same day.

1. Comprehensive Introduction & Overview

The Non-Tunneled Dialysis Catheter (NTDC), commonly referred to in clinical settings by the proprietary name "Quinton catheter," represents a cornerstone of acute vascular access in nephrology and critical care medicine. As a temporary, percutaneous venous access device, it is designed for short-term hemodialysis, hemoperfusion, or continuous renal replacement therapy (CRRT).

Unlike tunneled catheters (such as PermCath devices), which are anchored subcutaneously to reduce infection risk and facilitate long-term use, the non-tunneled catheter is inserted directly into a central vein and secured at the exit site with sutures. Because it lacks a subcutaneous cuff, it is intended for immediate use, typically in emergency or urgent clinical scenarios where rapid initiation of extracorporeal blood purification is life-saving.

2. Deep-Dive: Technical Specifications and Mechanisms

The Quinton catheter is a multi-lumen device (typically dual or triple lumen) constructed from radiopaque polyurethane. This material is chosen for its thermolastic properties, which allow it to soften at body temperature, thereby reducing the risk of vessel wall trauma.

Technical Characteristics

  • Lumen Configuration: Dual-lumen (one venous, one arterial) allows for simultaneous blood withdrawal and return.
  • Radiopacity: Essential for confirming tip placement via chest X-ray.
  • Stiffness: Engineered to be firm enough for insertion via the Seldinger technique but flexible enough to reside in the superior vena cava (SVC) or right atrium without causing mechanical irritation.
  • Flow Rates: Designed to support blood flow rates of 250–400 mL/min, which is sufficient for standard hemodialysis.

The Seldinger Technique Mechanism

The placement relies on the Seldinger technique, a gold-standard interventional procedure:
1. Vascular Access: Ultrasound-guided needle aspiration of the target vein.
2. Guidewire Placement: A flexible guidewire is threaded through the needle into the vein.
3. Dilation: Serial dilators are passed over the wire to create a subcutaneous and venous tract.
4. Catheter Insertion: The dialysis catheter is tracked over the wire into the target vessel.
5. Securing: The wire is removed, and the catheter is sutured to the skin.

3. Extensive Clinical Indications & Usage

The primary indication for a Quinton catheter is the urgent need for hemodialysis in patients who do not yet have a functional arteriovenous (AV) fistula or graft.

Clinical Indications

Indication Clinical Context
Acute Kidney Injury (AKI) Sudden loss of renal function requiring immediate metabolic stabilization.
End-Stage Renal Disease (ESRD) Presentation of a dialysis-naive patient with uremic symptoms.
Failed AV Access Thrombosis or infection of an existing fistula/graft requiring "bridge" access.
Toxin Removal Emergency hemodialysis for severe drug overdose or metabolic poisoning.
CRRT Initiation Hemodynamic instability in ICU patients requiring slow, continuous filtration.

Preferred Insertion Sites

  1. Right Internal Jugular (RIJ): The gold standard. It provides a straight anatomical path to the right atrium, minimizing the risk of kinking and ensuring optimal blood flow.
  2. Left Internal Jugular (LIJ): Second choice, though associated with a slightly higher risk of malpositioning.
  3. Femoral Vein: Reserved for emergency situations or when neck access is contraindicated. It is associated with higher infection rates and restricted patient mobility.
  4. Subclavian Vein: Generally avoided due to a high risk of vein stenosis, which can permanently compromise future AV fistula creation.

4. Risks, Side Effects, and Contraindications

While life-saving, the non-tunneled catheter is associated with significant morbidity. Clinicians must weigh the necessity of the procedure against potential complications.

Potential Complications

  • Infectious: Catheter-related bloodstream infections (CRBSI) are the most frequent complication. The lack of a cuff allows bacteria to migrate along the catheter tract into the bloodstream.
  • Mechanical: Pneumothorax (if the needle punctures the lung apex), arterial puncture (carotid artery), or hematoma formation.
  • Thrombotic: Catheter dysfunction due to fibrin sheath formation or blood clots within the lumen.
  • Vascular Injury: Venous stenosis or thrombosis, which can destroy the vasculature required for future long-term access.

Contraindications

  • Absolute: Local skin infection at the insertion site, severe uncorrected coagulopathy (relative), or anatomical obstruction of the target vein.
  • Relative: Severe obesity (making ultrasound visualization difficult), patient agitation/non-compliance, or anatomical anomalies.

5. Pre-Op and Post-Op Protocols

Pre-Operative Preparation

  1. Informed Consent: Detailed discussion of risks (bleeding, infection, pneumothorax).
  2. Imaging: Ultrasound-guided mapping of the target vein to ensure patency and anatomical safety.
  3. Coagulation Profile: Review of INR, PTT, and platelet count.
  4. Sterility: Strict adherence to maximal sterile barrier precautions (sterile gown, gloves, cap, large drape).

Post-Operative Recovery and Maintenance

  1. Imaging: Immediate portable chest X-ray to confirm tip placement in the SVC/RA junction and rule out pneumothorax.
  2. Dressing: Use of sterile, transparent semi-permeable dressings.
  3. Flush Protocols: Heparin or saline locks to maintain lumen patency between sessions.
  4. Monitoring: Daily assessment of the insertion site for erythema, purulence, or tenderness.

6. Alternative Treatments

When a Quinton catheter is contraindicated or insufficient, the following alternatives are considered:
* Tunneled Dialysis Catheters (TDC): For patients expected to need dialysis for >2 weeks.
* AV Fistula (AVF): The gold standard for long-term access, created surgically by connecting an artery to a vein.
* AV Graft (AVG): A synthetic conduit connecting an artery and vein, used when veins are unsuitable for a fistula.
* Peritoneal Dialysis (PD): An alternative modality using the peritoneal membrane as a filter.

7. Massive FAQ Section

Q1: How long can a Quinton catheter remain in place?
A: Ideally, it should be removed as soon as possible. In practice, it is often limited to 1–2 weeks due to the high risk of infection.

Q2: Why is the Right Internal Jugular vein preferred?
A: It offers a direct anatomical path to the right atrium, ensuring the highest blood flow rates and the lowest risk of mechanical dysfunction.

Q3: Can a patient shower with a Quinton catheter?
A: Generally, no. The site must remain dry to prevent bacterial migration. Specialized waterproof coverings are required if showering is permitted by the nephrologist.

Q4: What is the most common cause of catheter dysfunction?
A: Fibrin sheath formation or luminal thrombosis. Often, this is managed with thrombolytic agents (e.g., tPA) or catheter exchange over a wire.

Q5: Is ultrasound guidance necessary?
A: Yes. Current clinical guidelines mandate the use of real-time ultrasound to reduce the risk of arterial puncture and improve first-pass success rates.

Q6: What should I do if the catheter site starts bleeding?
A: Apply firm, manual pressure to the site and notify the medical team immediately. Do not remove the dressing until assessed by a clinician.

Q7: Can a Quinton catheter be used for medication administration?
A: No. It is strictly for dialysis. Using it for general IV medications increases the risk of infection and can lead to incompatible drug interactions within the circuit.

Q8: Why is a chest X-ray required after placement?
A: To verify that the catheter tip is in the correct position (usually the SVC or right atrium) and to ensure no pneumothorax occurred during the procedure.

Q9: What are the signs of a catheter-related infection?
A: Fever, chills, hypotension, or redness, swelling, and pus at the catheter exit site. This is a medical emergency.

Q10: Is the procedure painful?
A: The procedure is performed under local anesthesia (lidocaine). Patients may feel pressure, but should not experience sharp pain. Sedation may be used for anxious patients.

8. Clinical Summary and Outcomes

The Non-Tunneled Dialysis Catheter remains an indispensable tool for the acute management of renal failure. While its lifespan is limited and its complication profile higher than permanent access methods, its ability to provide immediate, high-flow vascular access makes it a life-saving intervention. Success in utilizing these devices relies heavily on sterile technique, ultrasound guidance, and diligent post-procedural nursing care.

For the clinician, the primary goal is the "Bridge to Success": using the Quinton catheter as a temporary measure while simultaneously planning for the creation of an autogenous AV fistula, which remains the superior long-term vascular access solution.

Share this procedure: